Healthcare provider profile · identity verified

Benjamin Monson, M.D.

Internal Medicine · WEST DES MOINES, IA · NPI 1962816512

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	637	186
Losartan Potassium	Losartan Potassium	409	111
Levothyroxine Sodium	Levothyroxine Sodium	278	70
Amlodipine Besylate	Amlodipine Besylate	276	87
Rosuvastatin Calcium	Rosuvastatin Calcium	227	68
Tamsulosin Hcl	Tamsulosin Hcl	209	67
Omeprazole	Omeprazole	207	66
Simvastatin	Simvastatin	197	54
Metoprolol Succinate	Metoprolol Succinate	193	55
Lisinopril	Lisinopril	187	52
Hydrochlorothiazide	Hydrochlorothiazide	182	53
Metformin Hcl	Metformin Hcl	165	47
Pantoprazole Sodium	Pantoprazole Sodium	159	47
Ozempic	Semaglutide	122	25
Furosemide	Furosemide	121	46
Eliquis	Apixaban	117	25
Allopurinol	Allopurinol	104	29
Fluoxetine Hcl	Fluoxetine Hcl	97	21
Pravastatin Sodium	Pravastatin Sodium	91	28
Gabapentin	Gabapentin	89	24
Duloxetine Hcl	Duloxetine Hcl	88	20
Alendronate Sodium	Alendronate Sodium	86	22
Tramadol Hcl	Tramadol Hcl	83	26
Potassium Chloride	Potassium Chloride	82	26
Finasteride	Finasteride	81	21
Trazodone Hcl	Trazodone Hcl	72	20
Glimepiride	Glimepiride	67	16
Metoprolol Tartrate	Metoprolol Tartrate	61	20
Zolpidem Tartrate	Zolpidem Tartrate	59	20
Jardiance	Empagliflozin	50	12
Spironolactone	Spironolactone	50	18
Lorazepam	Lorazepam	49	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	46	17
Albuterol Sulfate Hfa	Albuterol Sulfate	45	24
Clopidogrel	Clopidogrel Bisulfate	44	14
Carvedilol	Carvedilol	43	13
Meloxicam	Meloxicam	43	18
Atenolol	Atenolol	42	13
Clonazepam	Clonazepam	42	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	42	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	40	11
Prednisone	Prednisone	40	37
Cephalexin	Cephalexin	39	30
Januvia	Sitagliptin Phosphate	39	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	12
Sumatriptan Succinate	Sumatriptan Succinate	39	suppressed
Glipizide Er	Glipizide	38	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	37	11
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Bupropion Xl	Bupropion Hcl	34	suppressed
Glipizide	Glipizide	33	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Sertraline Hcl	Sertraline Hcl	33	11
Torsemide	Torsemide	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Azithromycin	Azithromycin	27	27
Metformin Hcl Er	Metformin Hcl	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Xarelto	Rivaroxaban	25	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	21
Fluticasone Propionate	Fluticasone Propionate	22	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Amoxicillin	Amoxicillin	19	17
Doxycycline Monohydrate	Doxycycline Monohydrate	19	13
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	13
Warfarin Sodium	Warfarin Sodium	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Nitroglycerin	Nitroglycerin	16	11
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Colchicine	Colchicine	15	11
Dilt-Xr	Diltiazem Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Famotidine	Famotidine	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Sulindac	Sulindac	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Ramipril	Ramipril	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error